To further explore and validate the potential translational implications of our study findings, it is essential to investigate NfL, MCP-1, and RANTES in cancer patients receiving neurotoxic anticancer drugs, particularly in relation to the occurrence of CIPN. Here, NEFL is linked to cancer.